Seeking to improve the immune effect of an iPSC‐based cancer vaccines while minimizing the risk of systemic toxicity, we here developed the RIVA using the chimeric photosensory protein FnBphP and its interaction partner LDB3. The gene discussed is LDB3; the disease is cancer.